Ontology highlight
ABSTRACT:
SUBMITTER: Sen KI
PROVIDER: S-EPMC5392168 | biostudies-literature | 2017 May
REPOSITORIES: biostudies-literature
Sen K Ilker KI Tang Wilfred H WH Nayak Shruti S Kil Yong J YJ Bern Marshall M Ozoglu Berk B Ueberheide Beatrix B Davis Darryl D Becker Christopher C
Journal of the American Society for Mass Spectrometry 20170119 5
Applications of antibody de novo sequencing in the biopharmaceutical industry range from the discovery of new antibody drug candidates to identifying reagents for research and determining the primary structure of innovator products for biosimilar development. When murine, phage display, or patient-derived monoclonal antibodies against a target of interest are available, but the cDNA or the original cell line is not, de novo protein sequencing is required to humanize and recombinantly express the ...[more]